1. Home
  2. EOLS vs SNDA Comparison

EOLS vs SNDA Comparison

Compare EOLS & SNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • SNDA
  • Stock Information
  • Founded
  • EOLS 2012
  • SNDA 1990
  • Country
  • EOLS United States
  • SNDA United States
  • Employees
  • EOLS N/A
  • SNDA N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • SNDA Hospital/Nursing Management
  • Sector
  • EOLS Health Care
  • SNDA Health Care
  • Exchange
  • EOLS Nasdaq
  • SNDA Nasdaq
  • Market Cap
  • EOLS 493.5M
  • SNDA 487.5M
  • IPO Year
  • EOLS 2018
  • SNDA 1997
  • Fundamental
  • Price
  • EOLS $7.66
  • SNDA $25.71
  • Analyst Decision
  • EOLS Strong Buy
  • SNDA Hold
  • Analyst Count
  • EOLS 5
  • SNDA 1
  • Target Price
  • EOLS $21.25
  • SNDA $26.00
  • AVG Volume (30 Days)
  • EOLS 1.2M
  • SNDA 17.1K
  • Earning Date
  • EOLS 11-05-2025
  • SNDA 08-11-2025
  • Dividend Yield
  • EOLS N/A
  • SNDA N/A
  • EPS Growth
  • EOLS N/A
  • SNDA N/A
  • EPS
  • EOLS N/A
  • SNDA N/A
  • Revenue
  • EOLS $277,941,000.00
  • SNDA $309,366,000.00
  • Revenue This Year
  • EOLS $14.01
  • SNDA $25.57
  • Revenue Next Year
  • EOLS $29.46
  • SNDA $6.76
  • P/E Ratio
  • EOLS N/A
  • SNDA N/A
  • Revenue Growth
  • EOLS 17.15
  • SNDA 26.39
  • 52 Week Low
  • EOLS $5.71
  • SNDA $19.34
  • 52 Week High
  • EOLS $17.82
  • SNDA $28.60
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 50.21
  • SNDA 52.83
  • Support Level
  • EOLS $7.19
  • SNDA $25.27
  • Resistance Level
  • EOLS $7.67
  • SNDA $25.92
  • Average True Range (ATR)
  • EOLS 0.34
  • SNDA 0.60
  • MACD
  • EOLS 0.13
  • SNDA -0.05
  • Stochastic Oscillator
  • EOLS 79.29
  • SNDA 45.89

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About SNDA Sonida Senior Living Inc.

Sonida Senior Living Inc is an owner operator of senior housing communities in the United States in terms of resident capacity. It provides senior living services to the elderly, including independent living, assisted living, Respite Care and Temporary Care Programs, Home Care Services, and memory care services. The company's objective is to provide value to residents by providing quality senior housing services at reasonable prices. The basic service of the company is comprised of meals, housekeeping, laundry, 24-hour staffing, transportation, social and recreational activities, and healthcare monitoring.

Share on Social Networks: